Mode
Text Size
Log in / Sign up

Group B Streptococcus Prevalence and Antimicrobial Resistance in African PopulationsNew data reveals high antibiotic resistance in Group B Streptococcus

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
High GBS transmission and significant tetracycline/cotrimoxazole resistance highlight the need for targeted vaccines and stewardship.

This meta-analysis provides a comprehensive overview of Group B Streptococcus (GBS) dynamics within African populations, focusing on maternal rectovaginal colonization, vertical transmission rates, and the distribution of specific serotypes. With a substantial sample size of 53,770, the study offers significant data for clinical practitioners managing neonatal and maternal health in these regions. The findings underscore the prevalence of GBS and the complexities of its transmission from mother to infant.

Data indicates that approximately 18% of the studied maternal population exhibited rectovaginal GBS colonization. While this percentage represents a significant portion of the population, the study highlights the critical role of maternal carriage as a primary source for neonatal infection. The identification of these carriage rates is essential for developing targeted screening protocols and intervention strategies to mitigate the risk of neonatal sepsis and other associated complications.

Vertical transmission of GBS was observed in 47% of cases, highlighting a high rate of transmission from mother to neonate. This significant finding underscores the importance of identifying and managing GBS in pregnant women to protect newborns. The high transmission rate suggests that maternal screening and subsequent prophylactic measures are vital components of obstetric care in the studied regions.

Regarding serotype distribution, the study identified a diverse range of strains. Maternal isolates showed a distribution of Serotype V (27%), Ia (24%), III (23%), and II (19%). Neonatal isolates showed a slightly different distribution, with Serotype V at 31%, Ia at 26%, III at 23%, and II at 15%. This diversity in serotypes suggests that multivalent vaccine strategies may be necessary to provide broad protection against the various circulating strains of GBS.

Antimicrobial resistance profiles revealed significant challenges for clinical management. The study found high resistance rates to tetracycline (87%) and cotrimoxazole (75%) among the isolates. These findings are critical for clinicians, as they indicate that these specific antibiotics may have limited efficacy in treating GBS infections in these regions. Such data necessitates careful consideration of empirical treatment guidelines and the selection of effective agents for neonatal infections.

Conversely, resistance to ampicillin and penicillin remained relatively low, with rates of 10% and 9% respectively. These findings suggest that beta-lactam antibiotics remain viable options for treating GBS infections in these populations. However, the high prevalence of resistance to other common agents necessitates a nuanced approach to antibiotic stewardship and the selection of appropriate therapies based on local resistance profiles.

In conclusion, the meta-analysis highlights the high prevalence of GBS and its diverse serotype distribution in Africa. The significant rates of vertical transmission and the specific patterns of antimicrobial resistance provide a clear roadmap for clinical intervention. These findings support the development of multivalent vaccines and emphasize the need for robust antibiotic stewardship to ensure effective treatment for both mothers and newborns.

How this fits prior evidence

How this fits prior evidence This meta-analysis provides specific data on Group B Streptococcus (GBS) in Africa, which complements other regional findings. While the study does not directly relate to the 42.6% of chicken products with antibiotic residues or the 6.7% Salmonella prevalence in Ethiopia, it addresses a gap in GBS-specific data in the region. It also highlights a need for stewardship, similar to the concerns regarding high rates of penicillin (85%) and third-generation cephalosporin (50%) resistance in K. pneumoniae in Burkina Faso.

When a pregnant woman carries certain bacteria, it can be passed to her newborn baby during birth. One specific type of bacteria, known as Group B Streptococcus (or GBS), is a common cause of infections in infants. For parents and healthcare providers, understanding how this bacteria behaves and how it reacts to medicine is vital for keeping babies safe.

To better understand the situation, researchers looked at data from over 53,000 cases involving pregnant women and newborns in Africa. They wanted to see how often mothers carried the bacteria, how often it moved from mother to baby, and which specific types of the bacteria were most common. Most importantly, they looked at how well common antibiotics, like penicillin and tetracycline, were still able to fight the infection.

The findings showed that about 18% of the mothers in the study carried the bacteria. Of those cases, the bacteria was passed to the baby about 47% of the time. The study also identified several different strains of the bacteria. While the types of bacteria found in mothers and babies were similar, the data showed that some specific types were much more common than others.

One of the most significant findings involved how the bacteria responded to medicine. The study found very high levels of resistance to two specific drugs: 87% of the bacteria were resistant to tetracycline, and 75% were resistant to cotrimoxazole. In contrast, the bacteria showed much lower resistance to penicillin (10%) and another drug called ampicillin (10%).

It is important to remember that this is one study looking at a specific region. While the high resistance to certain drugs is a serious finding, it does not mean that all treatments are failing. It highlights a specific need for careful medicine management to ensure the right drugs are used at the right time. For now, these results help doctors understand which tools they have available to protect mothers and their newborns from infection.

What this means for you:
High resistance to some antibiotics in Group B Streptococcus highlights the need for careful medicine management.

Study Details

Study typeMeta analysis
Sample sizen = 53,770
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
OBJECTIVES: We conducted a systematic review and meta-analysis to estimate maternal Group B Streptococcus (GBS) colonization, vertical transmission, serotype distribution, and antimicrobial resistance (AMR) burden of GBS in African pregnant women and newborn infants. METHODS: Literature searches were performed on CINAHL, EMBASE, Cochrane Library, Google Scholar, ProQuest, PsycINFO, MEDLINE/PubMed, WHO IRIS, Scopus, Web of Science, African Journals Online, and University repositories. Heterogeneity was evaluated using Cochrane's chi-square test and the I² statistics, and potential publication bias was assessed using Egger's regression intercept. RESULTS: A total of 116 studies from 29 African countries (n = 53,770 participants) were included. The pooled prevalence of maternal rectovaginal GBS colonization was 18% (95% confidence interval [CI]: 16%-20%). The pooled proportion of vertical transmission was 47% (95% CI: 39%-55%). Among maternal isolates, serotypes V (27%; 95% CI: 23%-32%), Ia (24%; 95% CI: 19%-29%), III (23%; 95% CI: 19%-26%), and II (19%; 95% CI: 13%-25%) were most frequently detected. Among neonatal isolates, serotypes V (31%; 95% CI: 22%-41%), Ia (26%; 95% CI: 17%-35%), III (23%; 95% CI: 15%-31%), and II (15%; 95% CI: 12%-19%) were identified. AMR was high for tetracycline (87%; 95% CI: 85%-88%) and cotrimoxazole (75%; 95% CI: 72%-78%), and low for β-lactams, including ampicillin (10%; 95% CI: 9%-12%) and penicillin (9%; 95% CI: 8%-11%). CONCLUSION: The prevalence of maternal GBS rectovaginal colonization and vertical transmission in Africa is high and comparable to global estimates, but there were marked regional variations. The predominance of serotypes V, Ia, and III supports their inclusion in multivalent vaccine formulations. Widespread resistance to tetracycline and cotrimoxazole and moderate macrolide resistance highlight the need for antimicrobial stewardship and ongoing surveillance.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.